V. De Mitrio

发表

Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections.

O. Schiraldi, V. Speciale, F. Scaraggi, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women.

R. Giorgino, G. Pergola, M. Sciaraffia, 1999, Metabolism: clinical and experimental.

Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.

O. Schiraldi, F. Scaraggi, R. Marino, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.

R. Giorgino, N. Pannacciulli, G. De Pergola, 2002, Obesity research.

Influence of free testosterone on antigen levels of plasminogen activator inhibitor-1 in premenopausal women with central obesity.

O. Schiraldi, R. Giorgino, G. Garruti, 1992, Metabolism: clinical and experimental.

Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.

A. Minenna, R. Giorgino, N. Pannacciulli, 1997, Metabolism: clinical and experimental.

A Family History of Type 2 Diabetes Is Associated with Lower Sensitivity to Activated Protein C in Overweight and Obese Premenopausal Women

R. Giorgino, N. Pannacciulli, M. Sciaraffia, 2001, Thrombosis and Haemostasis.

Beneficial effects of postmenopausal hormone replacement therapy with transdermal estradiol on sensitivity to activated protein C.

O. Schiraldi, G. De Pergola, E. Cicinelli, 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Severe venous thromboembolism in a young man with Klinefelter's syndrome and heterozygosis for both G20210A prothrombin and factor V Leiden mutations

G. De Pergola, V. Speciale, F. Scaraggi, 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Role of the 4G/5G Polymorphism of PAI-1 Gene Promoter on PAI-1 Levels in Obese Patients

A. Lombardi, R. Vettor, A. Girolami, 2001, Thrombosis and Haemostasis.

[Use of defibrotide in the treatment of Raynaud's phenomenon associated with progressive systemic sclerosis or essential mixed cryoglobulinemia].

F. Dammacco, V. De Mitrio, M. Petronelli, 1988, La Clinica terapeutica.

Immunoresponsiveness in hemophilia: lymphocyte- and phagocyte-mediated functions.

L. Bonomo, E. Jirillo, S. Antonaci, 1988, Diagnostic and clinical immunology.